'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release.
The authorization includes those 12 and up based on modeling that shows it would have similar effects in children as in adults if they were a certain weight, but Pfizer said in its release that the data from the new trial"will provide further support for the dose recommendations in this population, as well as potentially expand the indication to younger age groups and lower weights."
"There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death," said Dr. Mikael Dolsten, Pfizer's chief scientific officer and president of worldwide research, development and medical, in the release.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
Phase 2, 3 trial for Pfizer pill for COVID begins in children ages 6 to 17'There is a significant unmet need for outpatient treatments that can be taken by children and adolescents to help prevent progression to severe illness, including hospitalization or death.'
Read more »
Pfizer begins next phase of COVID-19 pill trial for childrenThe company announced Wednesday that it has started the second and third test phases for Paxlovid in children ages 6 to 17.
Read more »
Pfizer launches COVID pill clinical trial for childrenPfizer announced Wednesday that it has begun clinical trials of its COVID-19 pills in children ages 6 to 17.
Read more »
Pfizer launches clinical trial testing its COVID-19 pill in children aged 6 and older
Read more »